| HOME >> BIOLOGY >> TECHNOLOGY |
GENEART Extends Partnership with QIAGEN II-25
LC Sciences and DNAVision Enter into Strategic Marketing Alliance II-25
5. FOCUS ON SELECT PARTICIPANTS IN SYNTHETIC BIOLOGY II-26
AMYRIS BIOTECHNOLOGIES, INC. (US) II-26
ATG Biosynthetics GmbH (Germany) II-26
Blue Heron Biotechnology, Inc. (US) II-26
BP Plc. (UK) II-26
Chromatin Inc. (US) II-27
DNA2.0 (US) II-27
Draths Corp. (US) II-27
febit Synbio GmbH (Germany) II-28
GENEART AG (Germany) II-28
GenScript USA, Inc. (US) II-28
Gevo, Inc. (US) II-28
Joule Biotechnologies, Inc. (US) II-29
LC Sciences (US) II-29
LS9, Inc. (US) II-29
OPXBIO Inc. (US) II-30
Solazyme, Inc. (US) II-30
Sloning BioTechnology GmbH (Germany) II-30
Synthetic Genomics, Inc. (US) II-31
Verdezyne, Inc. (US) II-31
6. GLOBAL MARKET PERSPECTIVE II-32
Table 1: World Recent Past, Current and Future Analysis for
Synthetic Biology by End-Use Sector - Energy & Chemicals,
Biotechnology & Pharmaceuticals, and Research & Development
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart) II-32
Table 2: World 10-Year Perspective for Synthetic Biology by
End-Use Sector - Percentage Breakdown of Dollar Sales for
Energy & Chemicals, Biotechnology & Pharmaceuticals, and
Research & Development Markets for Years 2006, 2009 and 2015
(includes corresponding Graph/Chart) II-33
III. COMPETITIVE LANDSCAPE
Total Companies Profiled: 51 (including Divisions/Subsidiaries - 52)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 37
Canada 1
Europe 11
France 1
Germany 5
The United Kingd
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |